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Clinicopathologic and Histopathologic Renal Abnormalities in Dogs
with Coccidioidomycosis
L.R. Mehrkens, F.C. Mohr, and J.E. Sykes
Background: We observed evidence of protein-losing nephropathy in some dogs with coccidioidomycosis, suggestive of
immune complex glomerulonephritis (ICGN). The goal of this study was to understand the prevalence of renal histopatho-
logic lesions and proteinuria in dogs with coccidioidomycosis.
Hypothesis: Biochemical and histopathological evidence of glomerular lesions is present in dogs with coccidioidomycosis.
Animals: Hundred and fifty-six dogs with naturally occurring coccidioidomycosis.
Methods: Retrospective case series. Clinical information and results of clinicopathologic testing were retrieved from the
University of California, Davis Veterinary Medical Teaching Hospital (VMTH). Microscopic sections of renal tissue procured
from necropsy of dogs with coccidioidomycosis were examined to evaluate the nature and distribution of lesions.
Results: A total of 156 dogs with coccidioidomycosis were identified; 87 dogs had serum biochemistry and a urinalysis
performed, 17 had urine protein:creatinine ratios (UPCs), and 24 had renal tissue available for histopathology. Eleven (13%)
of the 87 dogs were azotemic, 55 (63%) were proteinuric (of which 14 [25%] had clinically relevant proteinuria defined as
≥3+ or ≥500 mg/dL), and 14 dogs had UPC ≥0.5 (range, 0.5–21.5, median 4.2). Thirteen (54%) of 24 dogs had renal
histopathologic lesions suggestive of ICGN. Seven of these dogs had urinalyses performed; 5 (71%) had clinically relevant
proteinuria as described above. Two dogs (33%) with normal glomeruli had granulomatous nephritis, 1 of which had intrale-
sional Coccidioides spherules.
Conclusions and Clinical Importance: Coccidioidomycosis should be considered as a possible contributor to glomerular
disease in dogs. Whether similar lesions occur in other mammalian hosts, including humans, warrants further investigation.
Key words: Coccidioides immitis; Immune complex glomerulonephritis; Proteinuria; Urine protein:creatinine ratio; Valley
fever.
Coccidioidomycosis is the most common systemicmycosis in dogs the southwestern United States.
Disease results from infection by the dimorphic, sapro-
phytic fungal organism Coccidioides immitis or Coccid-
ioides posadasii. Infection by Coccidioides spp. occurs in
a wide range of host species, including humans, a myr-
iad of domestic and exotic mammals, and, rarely, rep-
tiles.1 Also known as “valley fever”, coccidioidomycosis
is endemic in semiarid regions of California, Arizona,
New Mexico, Texas, and Northern Mexico and semi-
arid regions in South America. Inhalation is the most
common route of infection in both animals and humans
and typically occurs after fungal hyphae have desiccated
and matured into arthroconidia that are easily
aerosolized. The arthrospores are inhaled and dispersed
along the bronchiolar tree. Here, they undergo struc-
tural transformation into spherules, which enlarge and
undergo endosporulation. Eventually, new endospores
are released into the surrounding tissue and the cycle
continues until the host is able to mount an appropriate
immune response. Direct cutaneous inoculation of
arthrospores has been reported, but these instances are
rare and typically result in local granuloma formation.2
Infections caused by Coccidioides may be subclinical
or result in severe illness and death. Dissemination to
extrapulmonary organs is a potential sequela in some
animals. One study indicated that 80% of dogs develop
primary pulmonary infection whereas 20% develop dis-
seminated disease.3 Pulmonary coccidioidomycosis is
characterized by clinical signs that include chronic
cough, lethargy, and respiratory distress. Radiographic
pulmonary lesions may be characterized by interstitial
to nodular patterns, with hilar lymphadenomegaly.
Dogs with disseminated disease have wide variation in
clinical and clinicopathologic signs. Diagnosis by serol-
ogy is straightforward, although seropositive, subclini-
cally infected and seronegative, ill dogs have been
documented.4
Because dogs and humans share a common environ-
ment, dogs may serve as sentinels of human infection.5
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Human infection has steadily increased over the last
10 years, and coccidioidomycosis is considered a re-
emerging infectious disease.6 Dogs come into close con-
tact with soil, because of a closer proximity to the
ground and digging behavior, and may provide a
clearer delineation of broadly defined endemic regions.
In this sense, rapid recognition of Coccidioides infection
in dogs in a clinical setting may benefit human public
health as well as minimize morbidity in other dogs.
We have observed that some dogs with disseminated
coccidioidomycosis have concurrent biochemical evi-
dence of protein-losing nephropathy, but to date this
observation has not been well documented in the medi-
cal literature. Possible mechanisms include deposition of
antigen-antibody complexes at the level of the glomeru-
lus or renal damage caused by endospore formation
and associated pyogranulomatous inflammation. There-
fore, the goal of our current study was to characterize
the renal lesions and associated biochemical abnormali-
ties in dogs with disseminated Coccidioides infection.
Materials and Methods
Criteria for Selection of Cases
Electronic medical records of dogs examined at the University
of California-Davis William R. Pritchard Veterinary Medical
Teaching Hospital (VMTH) between 1990 and 2013 were searched
for dogs with a diagnosis of coccidioidomycosis with the keyword
(“coccid*”). Medical records were reviewed by 2 of the authors
(LM and JS). Dogs were included in the study if they had a diag-
nosis of coccidioidomycosis either based on culture of Coccidioides
spp. from tissues or body fluids; a serologic titer ≥1 : 2 by quanti-
tative immunodiffusion, or through positive qualitative immunod-
iffusion with concurrent supportive clinical findings; or,
identification of intralesional Coccidioides spherules by
histopathology.
Procedures
Eighteen variables relating to signalment, history, and results of
clinicopathologic testing and testing for other causes of proteinuria
were extracted from the electronic medical record of each case.
Not all variables could be obtained for every dog because diagnos-
tic tests, including assays for comorbidities, were performed at the
discretion of the primary clinician, based on the clinical abnormal-
ities present at the time of evaluation. The age of each dog was
recorded as the age at the time of diagnosis of coccidioidomycosis
rounded to the nearest whole year. If dogs were <1 year old, age
was recorded in months. Dogs were considered to have pulmonary
coccidioidomycosis if they had clinical signs consistent with respi-
ratory disease (eg, cough, dyspnea) and findings on thoracic radio-
graphy consistent with pulmonary coccidioidomycosis, in addition
to a positive anti-Coccidioides antibody titer (defined as ≥1 : 2),
identification of spherules in tissues obtained at biopsy or
necropsy, or both. Dogs were considered to have disseminated
coccidioidomycosis if they had radiographic or ultrasonographic
findings consistent with disseminated coccidioidomycosis (ie, lytic
or proliferative bone lesions, enlargement of abdominal lymph
nodes, organomegaly) with a positive anti-Coccidioides titer, identi-
fication of spherules in non-respiratory tissues obtained at biopsy
or necropsy, or both.
To identify dogs with renal disease, a subset of dogs was identi-
fied that either had (1) both a serum biochemistry panel and
urinalysis performed, (2) kidney tissue available for histopatho-
logic evaluation, either as a result of biopsy or necropsy, or both.
Azotemia was defined as a serum creatinine concentration
≥1.4 mg/dL according to the International Renal Interest Society
guidelines.7 Isosthenuria was defined as a urine specific gravity
(USG) of 1.008–1.012. Proteinuria was defined as the presence of
any protein on urine dipstick or by photometry. For the purpose
of our study, clinically relevant proteinuria was defined as 3+ or
4+ protein on urine dipstick or ≥500 mg/dL of protein as deter-
mined by photometry in the absence of bacteriuria, pyuria, and
hematuria or a urine protein:creatinine ratios (UPC) >5. Dogs
counted once for this purpose if they had both clinically relevant
proteinuria on urinalysis and a UPC >5. Clinically relevant protei-
nuria was considered to be suspicious for the presence of underly-
ing glomerular disease.
Renal Histopathology
Biopsy specimens were immersion fixed in 10% buffered forma-
lin for histologic analysis. Paraffin-embedded tissues were sec-
tioned at 5 lm thickness and stained with hematoxylin and eosin.
Additional sections were prepared for staining with periodic acid
Schiff, Masson’s trichrome, or the Jones methenamine silver
method. All microscopic sections were evaluated by a board-certi-
fied veterinary anatomic pathologist (FCM). Histologic features,
in aggregate, that suggested a diagnosis of immune complex
glomerulonephritis (ICGN) were hypercellularity in the peripheral
aspects of glomerular lobules and the mesangium, capillary wall
thickening, reduplication and remodeling, intracapillary neu-
trophils, nuclear pyknosis, and mesangial matrix expansion. Fea-
tures for non-ICGN cases (excluding normal glomeruli) included
mesangial hypercellularity, mesangial expansion, rare capillary wall
thickening, and remodeling.
Results
Overall Dataset
A total of 156 dogs with coccidioidomycosis were
identified. These ranged in age from 6 months to
13 years (median, 4 years). Fifty (32.1%) were castrated
males, 41 (26.3%) were intact males, 54 (34.6%) were
spayed females, and 11 (7.0%) were intact females. A
total of 52 breeds were represented. The most com-
monly represented breeds were Labrador retrievers
(n = 19), golden retrievers (n = 10), boxers (n = 8), Dal-
matians and Dalmatian mixes (n = 8), border collies
(n = 7), pitbull terriers (n = 6), weimaraners (n = 5),
Hungarian vizslas (n = 5), and German shorthaired
pointers (n = 5). Travel history was provided for 89
dogs. Thirty-three (37.1%) dogs had traveled to (or
resided in) Arizona, 4 to Nevada (4.5%), and 35
(39.3%) to central California (San Joaquin Valley).
Three dogs traveled to or resided in both Arizona and
central California.
A specific diagnosis of coccidioidomycosis was made
by serology with complement fixation (n = 105), gel
immunodiffusion, or both and concurrent supportive
clinical findings (n = 30), histopathology of biopsy spec-
imens (n = 8), fungal culture (n = 12), cytologic exami-
nation of lavage fluids, aspirates, or impression smears
(n = 2), and histopathology after necropsy (n = 12). In
some cases, multiple methods were used to make a diag-
nosis. Antibody titers to Coccidioides ranged from 1 : 2
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to 1 : 512 (median, 1 : 16). Other diagnostic tests per-
formed included CBC (n = 136), serum biochemistry
panel (n = 126), urinalysis (n = 88), aerobic bacterial
urine culture (n = 32), thoracic radiographs (n = 137),
abdominal ultrasound examination (n = 96), and
necropsy (n = 24).
A total of 87 (55.8%) dogs had disseminated coccid-
ioidomycosis and the remaining 69 (44.2%) had pul-
monary coccidioidomycosis.
Biochemical Evidence of Renal Injury
A total of 87 dogs had both a serum biochemistry
panel and urinalysis performed, 14 of which also had
kidney tissue available for histopathologic examination.
An additional 10 dogs had kidney tissue available for
histopathologic evaluation but did not have both a
serum biochemistry panel and urinalysis performed, and
thus the total number of dogs for which histopathology
was performed was 24. In these 24 dogs, kidney tissue
for histopathology was obtained at necropsy.
Of all dogs included in study, 11 dogs (7.1%) had
comorbidities identified at the time of diagnosis. These
consisted of neoplasia (1 dog each with cutaneous mast
cell tumor, histiocytic sarcoma, lymphoma, and myeloid
leukemia), culture-negative infective endocarditis, medi-
cally controlled hypothyroidism, megaesophagus, canine
monocytic ehrlichiosis, and Rocky Mountain spotted
fever (1 dog each).
Of the 87 dogs that had both a serum biochemistry
panel and urinalysis performed, 11 (12.6%) dogs were
azotemic. In these 11 dogs, serum creatinine concentra-
tion ranged from 1.4 to 3.2 mg/dL (median,
1.6 mg/dL). The median USG for all azotemic dogs
was 1.024. In the azotemic dogs, USG was <1.008 (1
dog), 1.008–1.012 (3 dogs), 1.013–1.020 (1 dog), 1.020–
1.030 (3 dogs), and >1.030 (3 dogs). None of the azote-
mic dogs, and only 6 of the remaining 76 dogs that had
both a serum biochemistry panel and urinalysis per-
formed, were reported to have received fluid treatment
before urine was collected.
A total of 55 (63.2%) of the 87 dogs had proteinuria
on urinalysis, including all 11 azotemic dogs. Fourteen
(25%) of these 55 dogs had clinically relevant protein-
uria. Proteinuria was semiquantified by dipstick in 44
dogs, 15 (27.3%) of which had trace protein, 12
(21.8%) had 1+ protein, 5 (9.1%) had 2+ protein, 9
(16.4%) had 3+ protein, and 3 (5.4%) had 4+ protein.
The remaining 11 dogs had urine protein determined in
mg/dL with a photometera and of these, 3 (5.4%) had
25 mg/dL, 3 (5.4%) had 75 mg/dL, 3 (5.4%) had
150 mg/dL, and 2 (3.6%) had 500 mg/dL of protein or
greater in the urine. The UPC was determined for 17
dogs, 16 of which had proteinuria on urinalysis. Of
those 17 dogs, 3 had a UPC <0.5, 3 had a UPC of 0.5–
2.0, 5 had a UPC of 2.1–5.0 (range, 3.1–4.7), and 6 had
a UPC >5.0 (range, 6.2–21.5). Two of the dogs with a
UPC >5 were azotemic.
In the 21 dogs with azotemia or clinically relevant
proteinuria, additional testing for comorbidities that
might be associated with renal injury consisted of
aerobic bacterial culture for urinary tract infections (12
dogs), immunofluorescent antibody (IFA) serology for
Ehrlichia canis (2 dogs), in-clinic ELISA serology for
vector-borne pathogensb (2 dogs), Leptospira serology
by the microscopic agglutination test (1 dog), and
ELISA for Dirofilaria antigen (1 dog). All of these diag-
nostic tests were negative.
One of the dogs in the study developed nephrotic
syndrome and died after treatment for coccidioidomy-
cosis. A necropsy was not performed. Although 8 other
dogs had mild hypercholesterolemia, biochemical evi-
dence of nephrotic syndrome (hypercholesterolemia and
hypoalbuminemia in conjunction with edema or ascites)
was not identified in any of the other dogs in the study.
Histologic Evaluation
Kidney sections from 7 of the 24 dogs that had renal
histopathology performed were stained only with H&E.
The remainder had additional stains applied. Thirteen
(54.1%) of the 24 dogs had histopathologic findings
suggestive of ICGN. Interstitial fibrosis was detected in
10 (41.7%) of the 24 dogs. Infarcts were noted in 2
dogs. Five dogs had glomerular mesangial hypercellu-
larity (not consistent with ICGN), 1 of which was diag-
nosed with renal lymphoma by histopathology. The
glomeruli of the remaining 6 dogs were normal by light
microscopic criteria, but 2 had granulomatous nephritis
(1 with intralesional Coccidioides spherules), 1 had mul-
tifocal lymphocytic and plasmacytic nephritis, and 1
had cortical interstitial and medullary fibrosis. Two of
the 6 dogs with apparently normal glomeruli had histo-
logically normal interstitial tissue.
Of dogs with glomerular lesions consistent with ICGN,
1 dog had pulmonary coccidioidomycosis and 12 had
disseminated infections. Seven dogs with ICGN had uri-
nalyses performed and 5 (71.4%) had clinically relevant
proteinuria. The UPC had been performed antemortem
in 3 dogs that had renal histopathology performed after
necropsy and were increased in all 3 dogs (4.7, 6.2, and
21.5). All 3 of these dogs had lesion patterns consistent
with ICGN. Eleven of the dogs with ICGN had serum
biochemistry panels performed antemortem and of those,
2 dogs were azotemic. Two cases without glomerular
lesions had proteinuria. One dog had interstitial nephritis
with intralesional spherules (75 mg/dL proteinuria), and
the other had systemic histiocytosis without renal
involvement (3+ proteinuria, 3+ hemoprotein).
Discussion
To our knowledge, ours is the first study to describe
biochemical and histopathological evidence of renal
injury in dogs with coccidioidomycosis, including
glomerular lesions suggestive of ICGN. Immune com-
plex glomerulonephritis is a common form of glomeru-
lar disease in dogs, with 1 study finding that
approximately half (48%) of all kidney tissue biopsied
because of suspected glomerular disease had ICGN.8
Underlying causes of ICGN in dogs include chronic
infections with arthropod-borne pathogens (especially
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Ehrlichia canis, Babesia canis, Leishmania spp., and
Dirofilaria immitis), but chronic Coccidioides spp. infec-
tion has not yet been identified as a possible underlying
cause.
In dogs that had a urinalysis and serum biochemistry
panel performed, azotemia was identified in 13% of
dogs and proteinuria in 63% of dogs with coccid-
ioidomycosis. Azotemia and proteinuria are relatively
insensitive and nonspecific measures of renal dysfunc-
tion, and there are limitations to the ability of the cut-
offs used in our study to identify renal dysfunction,
such as variation in reference ranges of serum creatinine
concentration with body size and test methodologies.7
Nevertheless, these findings together with the results of
histopathology suggest that renal dysfunction is present
in a proportion of dogs with coccidioidomycosis. Test-
ing for other causes of protein-losing nephropathies was
not consistently performed on dogs in this dataset and
would be an appropriate goal for a prospective study.
In reports of coccidioidomycosis in humans, laboratory
evidence of impaired renal function is rarely described.
In 1 study of 162 human patients with coccidioidomy-
cosis, 27% of cases had an abnormal urinalysis, defined
as the presence of proteinuria, pyuria, or hematuria.9
The magnitude of proteinuria in these human patients
was not reported. It is generally accepted that a UPC
>2.0 suggests proteinuria resulting from renal (tubular
or glomerular) pathology, and a UPC >5 is consistent
with glomerular lesions. Although only 15 of 55 dogs
with proteinuria in our study had UPCs performed, 5
had results consistent with glomerular proteinuria (UPC
>5). Urine protein:creatinine ratios were not determined
for 18 dogs that had proteinuria on urinalysis that was
≥2+ or ≥25 mg/dL, suggesting that moderate to severe
proteinuria may be under-recognized.
In our study, glomerular lesions compatible with
ICGN were identified in more than half (54%) of the
dogs for which biopsy results were available. When a
urinalysis was available, many of those dogs (71%) had
proteinuria reported as 3+ or 4+ or at least 500 mg/dL.
Biopsy samples from dogs should be evaluated with a
combination of light microscopy (LM), transmission
electron microscopy (TEM), and immunofluorescence
(IF), as is the standard in human medicine.8 Given the
retrospective nature of our study, we were only able to
evaluate biopsy samples by LM because tissue was not
preserved for other diagnostic methods. Although not
the gold standard, in 1 study, the sensitivity of LM
alone to detect ICGN lesions was 94%, with a speci-
ficity of 77%.10 This same study noted that in 25% of
cases, TEM either reversed or helped clarify an initial
LM diagnosis. Thus, although we could not always
definitively characterize the lesions visualized as ICGN,
the high sensitivity and relatively high specificity of LM
suggest that our study results approximate the incidence
of ICGN in our study population.
Pulmonary coccidioidomycosis was the only condi-
tion detected antemortem and at necropsy in 1 dog
with ICGN. This finding suggests the possibility that
persistent pulmonary coccidioidomycosis may stimulate
an immune response that leads to glomerular damage
and proteinuria. If ICGN can occur secondary to
chronic pulmonary coccidioidomycosis, concurrent
ICGN may be under-recognized if urinalysis is not
performed as part of the diagnostic evaluation for
coccidioidomycosis. More studies are needed to deter-
mine the prevalence and clinical relevance of protein-
uria in dogs with both pulmonary and disseminated
coccidioidomycosis.
In summary, we have documented evidence of
glomerular lesions in a proportion of dogs with chronic
coccidioidomycosis. Because ours was a retrospective,
descriptive study, more research is required to deter-
mine whether there is a causative association between
Coccidioides infection and glomerular lesions in dogs.
Future directions for these results would include using
IF to verify the presence of immune complexes in these
samples with ICGN-like lesions, which would be ideal
to confirm suspicions of ICGN. In the interim, dogs
with coccidioidomycosis should be more thoroughly
screened for proteinuria to initiate timely treatment. In
addition, testing dogs with protein-losing nephropathies
that have resided in Coccidioides-endemic areas for anti-
Coccidioides antibodies has the potential to identify an
underlying cause and therefore permit more effective
treatment of proteinuric renal disease.
Footnotes
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